Ray Lockard

Corporate Officer/Principal bei TSCAN THERAPEUTICS, INC.

Health Technology

Consumer Services

Profil

Ray Lockard is currently Chief Manufacturing & Quality Officer at TScan Therapeutics, Inc., starting in 2026.
Formerly, Mr. Lockard was Executive Director-CMC, QA & External Quality at Ultragenyx Pharmaceutical, Inc. from 2020 to 2021 and Head-Site Quality at Novartis Gene Therapies, Inc. from 2019 to 2020.
Education includes an undergraduate degree from Hampden-Sydney College and an MBA from Kenan-Flagler Business School.

Aktive Positionen von Ray Lockard

Unternehmen	Position	Beginn
TSCAN THERAPEUTICS, INC.	Corporate Officer/Principal	01.01.2024

Alle aktiven Positionen von Ray Lockard

Ehemalige bekannte Positionen von Ray Lockard

Unternehmen	Position	Ende
ULTRAGENYX PHARMACEUTICAL INC.	Corporate Officer/Principal	01.12.2021
AVEXIS INC	Corporate Officer/Principal	01.10.2020

Sehen Sie sich die Erfahrung von Ray Lockard im Detail an

Ausbildung von Ray Lockard

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Ray Lockard im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	5
Ultragenyx Pharmaceutical, Inc. Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases	Health Technology
Hampden-Sydney College Hampden-Sydney College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kenan-Flagler Business School Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novartis Gene Therapies, Inc. Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company	Health Technology
TScan Therapeutics, Inc. TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients	Health Technology